CSBRCHAMPIONS ONCOLOGY, INC.
- AccessWire
Champions Oncology Reports Revenue of $15.2 Million
Oncology services margin improves to 51%; Adjusted EBITDA increases to $671,000 Oncology services margin improves to 51%; Adjusted EBITDA increases to $671,000 HACKENSACK, NJ / ACCESS Newswire / September 10, 2026 ...
- AccessWire
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026
HACKENSACK, NJ / ACCESS Newswire / September 4, 2026 / Champions Oncology, Inc. , a global leader in clinically relevant oncology research models and translational solutions, will report its financial and ...
- AccessWire
Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging
New molecular imaging capabilities connect longitudinal radiopharmaceutical uptake with biodistribution, efficacy and clinically annotated PDX tumor biology in a single, U.S.-based workflow HACKENSACK, NJ / ACCESS ...
- AccessWire
Champions Oncology Reports Record Annual Revenue of $59 Million
Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA HACKENSACK, NJ / ACCESS Newswire / July 27, 2026 / Champions Oncology, Inc. , a global leader in clinically relevant oncology research models ...
- AccessWire
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
HACKENSACK, NJ / ACCESS Newswire / July 20, 2026 / Champions Oncology, Inc. , a global leader in clinically relevant oncology research models and translational solutions, will report its financial and ...
- AccessWire
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
Eight studies demonstrate how clinically relevant models and integrated data can reduce translational risk and guide development decisionsHACKENSACK, NJ / ACCESS Newswire / April 9, 2026 / Champions Oncology, Inc. ...
- AccessWire
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&DHACKENSACK, NJ / ACCESS Newswire / March 30, 2026 / Champions Oncology, Inc. , a leading ...
- AccessWire
Champions Oncology Reports Revenue of $16.6 Million
Company remains on track to deliver year-over-year revenue growth and positive adjusted EBITDA for the fiscal yearHACKENSACK, NJ / ACCESS Newswire / March 12, 2026 / Champions Oncology, Inc. , a leading ...
- AccessWire
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
HACKENSACK, NJ / ACCESS Newswire / March 5, 2026 / Champions Oncology, Inc. , a leading translational oncology research organization, will report its financial and operational results for the third quarter ended ...
- AccessWire
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
We remain on track to deliver year-over-year revenue growth and to generate positive adjusted EBITDA for the fiscal yearHACKENSACK, NJ / ACCESS Newswire / December 15, 2025 / Champions Oncology, Inc. , a ...
- AccessWire
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
HACKENSACK, NJ / ACCESS Newswire / December 8, 2025 / Champions Oncology, Inc. , a leading translational oncology research organization, will report its financial and operational results for the second quarter ...
- SEC
8-K Form - Current report, item 5.07 - CHAMPIONS ONCOLOGY, INC. (0000771856) (Filer)
Current report, item 5.07 ...
- Earnings Call Transcripts
Champions Oncology, Inc. (CSBR) Q1 2026 Earnings Call Transcript
Champions Oncology, Inc. (CSBR) Q1 2026 Earnings Call Transcript ...
- SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - CHAMPIONS ONCOLOGY, INC. (0000771856) (Filer)
Quarterly report [Sections 13 or 15(d)] ...
- AccessWire
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
This release contains a headline correction from the previous publication.Positive start to FY 2026 with steady revenue, data growth and new leadership HACKENSACK, NJ / ACCESS Newswire / September 15, 2025 / Champions ...
- SEC
8-K Form - Current report, items 2.02 and 9.01 - CHAMPIONS ONCOLOGY, INC. (0000771856) (Filer)
Current report, items 2.02 and 9.01 ...
- AccessWire
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
Positive start to FY 2026 with steady revenue, data growth and new leadership HACKENSACK, NJ / ACCESS Newswire / September 15, 2025 / Champions Oncology, Inc. , a leading translational oncology research ...
- AccessWire
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
HACKENSACK, NJ / ACCESS Newswire / September 10, 2025 / Champions Oncology, Inc. , a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its ...
- SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - CHAMPIONS ONCOLOGY, INC. (0000771856) (Filer)
Additional definitive proxy soliciting materials and Rule 14(a)(12) material ...
- SEC
DEF 14A Form - Other definitive proxy statements - CHAMPIONS ONCOLOGY, INC. (0000771856) (Filer)
Other definitive proxy statements ...
- SEC
10-K Form - Annual report [Section 13 and 15(d), not S-K Item 405] - CHAMPIONS ONCOLOGY, INC. (0000771856) (Filer)
Annual report [Section 13 and 15(d), not S-K Item 405] ...
- SEC
8-K Form - Current report, items 2.02 and 9.01 - CHAMPIONS ONCOLOGY, INC. (0000771856) (Filer)
Current report, items 2.02 and 9.01 ...
- AccessWire
Champions Oncology Reports Record Annual Revenue of $57 Million
Total annual revenue growth of 14% HACKENSACK, NJ / ACCESS Newswire / July 23, 2025 / Champions Oncology, Inc. , a leading translational oncology research organization, today announced its financial results ...
- SEC
8-K Form - Current report, item 9.01 - CHAMPIONS ONCOLOGY, INC. (0000771856) (Filer)
Current report, item 9.01 ...
- AccessWire
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
HACKENSACK, NJ / ACCESS Newswire / July 21, 2025 / Champions Oncology, Inc. , a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and ...